Bio-Me’s Precision Microbiome Profiling (PMP™) technology is empowering rapid, accurate, and actionable analysis of the gut, skin, and vaginal microbiomes.

Precision Microbiome Profiling (PMP™)

PMP™ is a qPCR-based approach on Thermo Fisher Scientific’s OpenArray® platform. This allows PMP™ to deliver accurate and detailed information about the microbiome in a high-throughput format, which is readily available for interpretation, and in a faster timeframe than traditional microbiome analysis approaches.

Unique Microbiome Biobank Access

Through our special collaboration with HUNT4, a large-scale and population-based observational cohort, we have access to fecal samples from 13300 individuals, as well as to their anonymized medical registries with more than 6000 different health parameters. This enables microbiome discovery of novel biomarkers and drug targets.

At the heart of our technology is our assay design pipeline, whereby each microbial target is carefully selected due to prevalence, abundance, and physiological relevance. Thereafter, a thorough assay design and validation process is performed (in silico & ‘wet-lab’), culminating in creation of panels with repertoires of highly relevant targets to deliver reliable and reproducible microbiome profiling results.